Investigating muscle oxygenation in rheumatoid arthritis patients
Official title: Investigation of Respiratory Muscle Strength, Respiratory Muscle Endurance and Muscle Oxygenation in Patients With Rheumatoid Arthritis
Run by Kirsehir Ahi Evran Universitesi · NCT06769386 · Data updated 2026-11-12
This study is testing how well the muscles of people with rheumatoid arthritis work compared to healthy individuals to see how it affects their ability to exercise and stay active.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Kirsehir Ahi Evran Universitesi Academic / other |
| Locations | 1 site (Kırşehir, Merkez) |
| Status | Recruiting |
| Started | January 25, 2025 |
| Main results expected | January 25, 2026 |
| Study ends | January 25, 2027 |
| Registry record updated | February 11, 2025 |
| Trial ID | NCT06769386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-65 diagnosed with rheumatoid arthritis who are willing to participate.
✕Probably not a fit
Patients with serious cardiopulmonary, neurological, or orthopedic conditions, or those who have recently engaged in structured exercise programs, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore respiratory muscle strength, endurance, and muscle oxygenation in patients with rheumatoid arthritis compared to healthy individuals. It focuses on understanding how these factors affect exercise capacity and overall physical function in RA patients, who often experience pain and fatigue that limit their activity levels. By assessing both upper and lower extremity exercise capacity, the study seeks to uncover the physiological reasons behind muscle dysfunction in rheumatoid arthritis. The findings could provide insights into the impact of RA on physical health and inform future interventions.
Why it matters
Potential benefit: If successful, this study could enhance understanding of muscle function in rheumatoid arthritis, leading to improved management strategies and quality of life for patients.
How similar studies have gone: While the specific focus on muscle oxygenation in rheumatoid arthritis may be novel, similar studies have shown that understanding exercise capacity and muscle function can lead to significant improvements in patient care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Rheumatoid Arthritis Group Inclusion Criteria: * Patients diagnosed with rheumatoid arthritis, * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study. Exclusion Criteria: * Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions, * Participated in a planned exercise program in the last three months, * Cognitive impairment that will cause difficulty in understanding and following exercise test instructions, * Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study. Control Group Inclusion Criteria: * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study. Exclusion Criteria: * Diagnosed chronic or systemic disease, * Regular exercise (physical activity) 3 days a week, 150 minutes/week of moderate intensity * Smoking 10 packs x years or more, * Pneumonia or any acute infection, * Healthy individuals with any psychiatric disorder will not be included in the study.
Where it's running
-
Kırşehir Ahi Evran University, Physical Therapy and Rehabilitation Center, Cardiopulmonary Unit
Kırşehir, Merkez, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Başak KAVALCI KOL, PhD — Kirsehir Ahi Evran Universitesi
- Study coordinator: Başak KAVALCI KOL, PhD
- Email: basak.kavalci@ahievran.edu.tr
- Phone: +903862802317
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
GenAI-assisted RA bone erosion risk and DMARD choice
This study tests whether GenAI-based decision support can help doctors assess rheumatoid arthritis bone erosion risk and pick DMARDs for newly diagnosed inpatients.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Telitacicept for difficult-to-treat rheumatoid arthritis
This study tests whether adding telitacicept to standard therapy helps adults with hard-to-treat rheumatoid arthritis see better control of their symptoms.
-
PTC844 in people with active rheumatoid arthritis
This study tests whether PTC844 is safe and how it behaves in the body compared with placebo for people with active rheumatoid arthritis.
-
First-in-human test of CND319 in healthy people and people with rheumatic diseases
This early study tests whether CND319 is safe and tolerable and whether it shows any signs of activity in healthy adults and in people with rheumatoid arthritis or Sjogren's syndrome.
-
IV sarilumab for adults with rheumatoid arthritis
This study tests IV sarilumab to see how it works and how safe it is for adults with moderately to severely active rheumatoid arthritis, with or without certain standard arthritis medicines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.